EUVIMEDEUVIMED entdecken
EditorialOpen Access

GLP-1 receptor agonists: panacea or affirmation of societal failure?

Tomazo J Kallis, Rupert A Payne

British Journal of General Practice · 2025-04 · 75 (753) · 148-149

DOI: 10.3399/bjgp25x741069 ↗

Kurz gefasst

Editorial in der Zeitschrift British Journal of General Practice, online erschienen am 27.03.2025. Verfasst von Tomazo J Kallis und 1 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacist, Clinical Research Fellow; Health and Community Sciences, University of Exeter, Exeter. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Clinical Pharmacist, Clinical Research Fellow; Health and Community Sciences, University of Exeter, Exeter.
  • Professor of Primary Care and Clinical Pharmacology; Health and Community Sciences, University of Exeter, Exeter.

Zitieren

APA

Kallis, T. J., & Payne, R. A. (2025). GLP-1 receptor agonists: panacea or affirmation of societal failure?. British Journal of General Practice, 75(753), 148-149. https://doi.org/10.3399/bjgp25x741069

Vancouver

Kallis TJ, Payne RA. GLP-1 receptor agonists: panacea or affirmation of societal failure?. British Journal of General Practice. 2025;75(753):148-149. doi:10.3399/bjgp25x741069

BibTeX
@article{Kallis2025,
  author = {Kallis, Tomazo J and Payne, Rupert A},
  title = {GLP-1 receptor agonists: panacea or affirmation of societal failure?},
  journal = {British Journal of General Practice},
  year = {2025},
  volume = {75},
  number = {753},
  pages = {148--149},
  doi = {10.3399/bjgp25x741069}
}
Kostenlos starten →